Singapore Cardiac Surgery Instruments Market Report 2022 to 2030

Singapore Cardiac Surgery Instruments Market Analysis

$ 3999

The Singapore Cardiac Surgery Instruments Market is expected to witness growth from $2 Mn in 2022 to $4 Mn in 2030 with a CAGR of 7.20% for the forecasted year 2022-2030. Cardiovascular conditions such as coronary artery disease, heart failure, and arrhythmias are becoming more prevalent in Singapore due to factors such as the ageing population, sedentary lifestyles, and unhealthy diets. As a result, there is now greater demand for the tools and techniques used in heart surgery. The market is segmented by type, application and by end user. Some key players in this market include Biosensors International, Inzign Pte, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.

ID: IN10SGMD004 CATEGORY: Medical Devices GEOGRAPHY: Singapore AUTHOR: Jigyasu Bhandari

Buy Now

Singapore Cardiac Surgery Instruments Healthcare Market Executive Analysis

The Singapore Cardiac Surgery Instruments Market size is at around $2 Mn in 2022 and is projected to reach $4 Mn in 2030, exhibiting a CAGR of 7.20% during the forecast period. Government healthcare expenditure in Singapore is $13.65 billion in 2023 and triple to $36 billion by 2029. Singapore's healthcare sector is expected to expand by 9%, from $21.4 billion in 2017 to $23 billion in 2023. The sector is anticipated to have more than doubled, hitting $49.4 billion, by 2029. In Singapore, healthcare spending, which includes both state and private costs, is anticipated to make up 5.9% of GDP in 2019 and as much as 9% by 2029.

In Singapore, cardiac surgery is a specialist area of medicine, and there are numerous hospitals and medical facilities that provide cardiac surgery services. For the best possible patient treatment, these facilities are outfitted with cutting-edge surgical tools and technologies. Instruments used in cardiac surgery are used in Singapore to control and treat a variety of cardiac conditions. These tools are used in a range of operations, such as minimally invasive cardiac surgery, valve repair or replacement, and coronary artery bypass grafting. In order to help surgeons, perform complex cardiac operations with greater accuracy and precision and potentially enhance patient outcomes, instruments for cardiac surgery are developed. There are many minimally invasive instruments used in cardiac surgery, enabling smaller incisions and less traumatic procedures. As a result, patients might feel less discomfort and need less time to recover. By reducing the time required to finish cardiac operations, the use of cardiac surgery instruments enables hospitals to perform more treatments and shorten patient wait times. Cardiac surgery tools can improve patient outcomes by reducing the chance of complications, hastening healing times, and raising the level of care generally.

Singapore Cardiac Surgery Instruments Market Analysis

Market Dynamics

Market Growth Drivers

Cardiovascular diseases such as coronary artery disease, heart failure, and arrhythmias are becoming more prevalent in Singapore due to factors such as the senior population, sedentary lifestyles, and unhealthy diets. As a result, there is now greater demand for the tools and techniques used in heart surgery. The healthcare system in Singapore is well-established, and a number of institutions and clinics provide cardiac surgery services. Due to this, there are now more devices available for cardiac surgery, which has boosted market growth in the Singapore healthcare market. The Singaporean government has put in place a number of programs to improve the healthcare system and promote the growth of the medical technology sector. These initiatives have produced a favourable atmosphere for manufacturers of cardiac surgery instruments, driving market development. The cost of healthcare in Singapore is among the peak in the world, with a sizable part of the budget going toward the treatment of heart conditions. Due to this, the demand for tools and procedures used in cardiac surgery has grown, propelling market expansion.

Market Restraints

In Singapore, cardiovascular surgery has risks, just like any other type of operation, such as bleeding, infection, and problems with anaesthesia. The demand for heart surgery tools and techniques may be constrained by these dangers. Due to their specialized design and the materials used in their manufacture, instruments used in cardiac surgery are frequently costly. For some hospitals and medical facilities, particularly those with tight budgets, this might be a deterrent to adoption.

Competitive Landscape

Key Players

Biosensors International (SG)
Inzign Pte (SG)
LivaNova
B. Braun
KLS Martin
Medline Industries
STILLE

Healthcare Policies and Regulatory Landscape

The Health Sciences Authority (HSA) is the Singaporean controlling authority in control of monitoring instruments used in cardiac surgery. The HSA is in charge of supervising the regulation of medical devices, which includes approving new devices, perceiving their effectiveness and safety, and enforcing regulatory acquiescence. Before they can be used in Singapore, medical equipment, including instruments used in cardiac surgery, must pass stringent testing and adhere to strict guidelines. Medical devices and treatments are gaged for their safety, effectiveness, and cost-effectiveness through the HTA procedure. The Agency for Care Effectiveness (ACE), which directs the Ministry of Health on the adoption and use of novel medical technologies and therapies, conducts HTA in Singapore. The Ministry of Health in Singapore requires all healthcare workers to hold a license. This covers medicinal facilities like clinics, hospitals, and product makers. By requiring licenses, manufacturers and healthcare workers can demonstrate compliance with rules and standards.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cardiac Surgery Instruments Market Segmentation

By Type (Revenue, USD Billion):

The market is divided into segments in this study based on the goods, applications, end users, and geographical areas. The market is divided into forceps, scissors, needle holders, clamps, and other cardiac surgery instruments based on the product. In 2017 the forceps category led the market, and it is anticipated that it will increase at the fastest rate going forward. The rise in heart surgeries and the frequent usage of forceps in most cardiac procedures are credited with the segment's strong growth.

Forceps
Vascular Forceps
Grasping Forceps
Other Forceps
Needle Holders
Scissors
Clamps
Other Cardiac Surgical Instruments

By Application (Revenue, USD Billion):

The market is further segmented by application into paediatric cardiac surgery, heart valve surgery, coronary artery bypass graft (CABG), and other applications. The Singapore market's largest and fastest-growing application segment is CABG. This is mostly explained by the increased prevalence of heart illnesses and the consequent rise in surgical treatments. The second-largest category is heart valve surgery.

Coronary Artery Bypass Graft (CABG)
Heart Valve Surgery
Pediatric Cardiac Surgery
Other Applications

By End User (Revenue, USD Billion):

Based on the end user, the market is segmented into hospitals and cardiac centers, and ambulatory surgery centers. The hospitals and cardiac centers segment is expected to dominate the market for cardiac surgery instruments. Growth in this end-user segment can be attributed to the increasing incidence of cardiac and heart valve diseases and the subsequent increase in the number of cardiac surgery procedures.

Hospitals and Cardiac Centers
Ambulatory Surgery Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.